NEW BRUNSWICK, N.J.,
Jan. 10, 2022 /PRNewswire/ -- The
Johnson & Johnson Medical Devices Companies (JJMDC)* today
announced that it will collaborate with Microsoft to further enable
and expand JJMDC's secure and compliant digital surgery ecosystem.
The Microsoft Cloud will help JJMDC realize its vision of driving
innovation that advances skills, improves workflow, and enhances
surgical decision making for a better overall customer experience
and improved patient and economic outcomes.
JJMDC's innovative medical technology exists across an ecosystem
that includes next generation robotics, world-class
instrumentation, advanced imaging and visualization, data and
analytics, artificial intelligence, machine learning, and
digital solutions. To mobilize the potential of these assets
and make a clinical difference for patients, it is imperative to
establish robust connectivity with, and between, all elements of
the ecosystem with a seamless, interconnected network that meets
surgeons where they are in their workflow and patients where they
are in their healthcare journey.
"Collaborating with Microsoft will help take our digital
approach to the next level as we create a best-in-class, unified
platform across our innovative surgical technologies," said
Larry Jones, Group CIO and Global
Vice President, Medical Devices, Johnson & Johnson. "It brings
together our collective expertise and is an exciting step towards
creating a connected patient journey across the entire care
continuum, before, during, and after a procedure."
As part of the strategic partnership, Microsoft will serve as
JJMDC's preferred cloud provider for the company's digital surgery
solutions and help JJMDC build out its digital surgery platform and
internet of things (IoT) device connectivity. By harnessing the
power of the Microsoft Cloud, including Azure, artificial
intelligence (AI), and machine learning, Microsoft 365 and Dynamics
365, the companies expect to work together to deliver innovation
across the following areas:
- Innovating to improve patient outcomes through artificial
intelligence, machine learning and data insights.
- Increasing JJMDC device connectivity, insights and intelligence
using Azure IoT and Edge Computing technologies.
- Increasing the pace of digital innovation and transformation
across the JJMDC digital surgery ecosystem using Azure capabilities
and services.
"At the Johnson & Johnson Medical Devices companies, we're
shaping a future where medical intervention is smarter,
less invasive, and more personalized," said Peter Schulam, MD, PhD, Global Head, Medical
Affairs, Clinical Affairs and Pre-Clinical Research, Johnson &
Johnson Medical Devices Companies, and Leader, Office of Digital
Innovation. "We're excited to collaborate with Microsoft on this
important work as we continue to expand our digital surgery assets
and capabilities, develop innovative and advanced instrumentation,
and make a meaningful clinical difference for customers and
patients."
About Johnson & Johnson Medical Devices
Companies:
At Johnson & Johnson Medical Devices Companies, we are helping
people live their best lives. Building on more than a century of
expertise, we tackle pressing healthcare challenges, and take bold
steps that lead to new standards of care while improving people's
healthcare experiences. In surgery, orthopaedics, vision and
interventional solutions, we are helping to save lives and paving
the way to a healthier future for everyone, everywhere.
Cautions Concerning Forward-Looking Statements
This press release contains "forward-looking statements" as defined
in the Private Securities Litigation Reform Act of 1995 regarding
the Johnson & Johnson Medical Devices Companies digital surgery
ecosystem. The reader is cautioned not to rely on these
forward-looking statements. These statements are based on current
expectations of future events. If underlying assumptions prove
inaccurate or known or unknown risks or uncertainties materialize,
actual results could vary materially from the expectations and
projections of Medical Device Business Services, Inc., the Johnson
& Johnson Medical Device Companies and/or Johnson &
Johnson. Risks and uncertainties include, but are not limited to:;
uncertainty of commercial success; manufacturing difficulties and
delays; competition, including technological advances, new products
and patents attained by competitors; challenges to patents; product
efficacy or safety concerns resulting in product recalls or
regulatory action; changes in behavior and spending patterns of
purchasers of health care products and services; changes to
applicable laws and regulations, including global health care
reforms; and trends toward health care cost containment. A further
list and descriptions of these risks, uncertainties and other
factors can be found in Johnson & Johnson's Annual Report on
Form 10-K for the fiscal year ended January
3, 2021, including in the sections captioned "Cautionary
Note Regarding Forward-Looking Statements" and "Item 1A. Risk
Factors," and in the company's subsequent Quarterly Reports on Form
10-Q and other filings with the Securities and Exchange Commission.
Copies of these filings are available online
at www.sec.gov, www.jnj.com or on request from
Johnson & Johnson. None of the Medical Device Business
Services, Inc., the Johnson & Johnson Medical Devices Companies
nor Johnson & Johnson undertakes to update any forward-looking
statement as a result of new information or future events or
developments.
*The Johnson & Johnson Medical Devices Companies comprise the
surgery, orthopaedics, vision and interventional solutions
businesses within Johnson & Johnson's Medical Devices segment.
The legal entity named in this agreement is Medical Device Business
Services, Inc.
Media Contact:
Jessica Castles Smith
(732) 501-8181
JCastlsm@its.jnj.com
Investor Contact:
Sarah Wood
(732) 524-2617
SWood15@its.jnj.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-medical-devices-companies-announces-strategic-partnership-with-microsoft-to-further-enable-its-digital-surgery-solutions-301456209.html
SOURCE Johnson & Johnson Medical Devices Companies